Filing Flows › Sunshine Biopharma (SBFM) › How it makes money
How Sunshine Biopharma (SBFM) makes money
Sunshine Biopharma (SBFM) made $9.3M of revenue in the second quarter 2026 (Q2 2026), -2% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $9.3M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $9.3M | -2% |
| Q1 2026 | $8.1M | -9% |
| Q4 2025 | $8.6M | -11% |
| Q3 2025 | $9.4M | +12% |
| Q2 2025 | $9.4M | +1% |
| Q1 2025 | $8.9M | +18% |
| Q4 2024 | $9.6M | +25% |
From Sunshine Biopharma's 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Sunshine Biopharma make money?
Sunshine Biopharma (SBFM) made $9.3M of revenue in the second quarter 2026 (Q2 2026), -2% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.